Single Arm Study Of Alxn1210 In Complement Inhibitor Treatment- Naïve Adult And Adolescent Patients With Atypical Hemolytic Uremic Syndrome (Ahus)
Posted Date: Aug 13, 2017
- Investigator: Neetu Radhakrishnan
- Specialties: Hematology Oncology, Oncology, Cancer
- Type of Study: Drug
Alexion ALXN1210-aHUS-311
Criteria:
To Be Eligible To Participate In This Study, Patients Must Have Atypical Hemolytic Uremic Syndrome (A Condition That Causes Blood Clots In Small Blood Vessels Throughout The Body).
Keywords:
Ahus, Alxn1210-Ahus-311, Atypical Hemolytic Uremic, Cancer, Hem
For More Information:
Uc Cancer Institute
513-584-7698
cancer@uchealth.com